Publications

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.

Uyoga, S; ADETIFA, IM O; OTIENDE, M; Yegon, C; AGWEYU, A; Warimwe, GM; SCOTT, JA G;

2021

Journal of the American Medical Association, (2021).326 14 10.1001/jama.2021.15265.

SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries.

Verelst, F; Hermans, L; Vercruysse, S; Gimma, A; Coletti, P; Backer, JA; Wong, KL M; Wambua, J; VAN ZANDVOORT, K; Willem, L; Bogaardt, L; Faes, C; JARVIS, CI; Wallinga, J; EDMUNDS, WJ; Beutels, P; Hens, N;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-02133-y.

Estimation of all-cause excess mortality by age-specific mortality patterns for countries with incomplete vital statistics: a population-based study of the case of Peru during the first wave of the COVID-19 pandemic.

Sempé, L; Lloyd-Sherlock, P; Martínez, R; Ebrahim, S; MCKEE, M; Acosta, E;

2021

Lancet Regional Health. Americas, (2021).2, 10.1016/j.lana.2021.100039.

Understanding and tracking the impact of long COVID in the United Kingdom.

Routen, A; O'Mahoney, L; Ayoubkhani, D; Banerjee, A; Brightling, C; Calvert, M; Chaturvedi, N; Diamond, I; EGGO, R; Elliott, P; Evans, RA; Haroon, S; Herret, E; O'Hara, ME; Shafran, R; Stanborough, J; Stephenson, T; Sterne, J; Ward, H; Khunti, K;

2021

Nature medicine, (2021).28 1 10.1038/s41591-021-01591-4.

Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine.

World Health Organisation SAGE Working Group on CO,;

2021

Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine (2021).

Time to evaluate COVID-19 contact-tracing apps.

Colizza, V; Grill, E; Mikolajczyk, R; Cattuto, C; KUCHARSKI, A; Riley, S; Kendall, M; Lythgoe, K; Bonsall, D; Wymant, C; Abeler-Dörner, L; Ferretti, L; Fraser, C;

2021

Nature medicine, (2021).27 3 10.1038/s41591-021-01236-6.

SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks.

Abu-Raddad, L; CHEMAITELLY, H; Coyle, P; Malek, J; Ahmed, A; Mohamoud, Y; Younuskunju, S; Ayoub, H; Kanaani, ZA; Kuwari, EA; Butt, A; Jeremijenko, A; Kaleeckal, AH; Latif, AN; Shaik, RM; Rahim, HA; Nasrallah, G; Yassine, H; Al Kuwari, M; Romaihi, HE A; Al-Thani, M; Khal, AA; Bertollini, R;

2021

medRxiv (2021). 10.1101/2021.01.15.21249731.

On the role of statisticians and modelers in responding to AIDS and COVID-19.

Jewell, BL; JEWELL, NP;

2021

Statistics in medicine, (2021).40 11 10.1002/sim.8943.

Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa.

KASEJE, N; Oruenjo, K; Kaseje, D; Evans, TG; Tanner, M; HAINES, A; Nyikal, J;

2021

BMJ global health, (2021).6 5 10.1136/bmjgh-2021-006289.

Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.

Read, JM; Green, CA; Harrison, EM; Docherty, AB; FUNK, S; Harrison, J; Girvan, M; Hardwick, HE; Turtle, L; Dunning, J; Nguyen-Van-Tam, JS; Openshaw, PJ; Baillie, JK; Semple, MG; ISARIC4C investigators,;

2021

Lancet, (2021).398 10305 10.1016/S0140-6736(21)01786-4.